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Time Course of Endothelial Dysfunction in Diabetes Mellitus
In a recent article, Dr Johnstone and coworkers1 describe an impaired endothelium-dependent vasodilation in patients with diabetes type I. They suggest their findings to be comparable to numerous studies showing such results in diabetic animals or isolated vessel strips as a result of endothelial dysfunction. In our opinion, some points of their article deserve further discussion.
In early uncomplicated stages of diabetes type I, increased blood flow is found in tissues prone to vascular complications such as kidney2 or retina.3 This increased flow has been related by Dr Williamson's group and ourselves to a glucose-mediated increase in the formation of endothelium-derived relaxing factor.45 Similar results have been observed by Houben et a16 in vivo for skin blood flow in patients with diabetes type I. In their article they also clearly showed that this increased skin blood flow decreases with the occurrence of overt diabetic angiopathy (ie, retinopathy).
These findings lead to the main point discussed in the article by Dr Johnstone et al.
In their study the authors have only excluded patients with overt evidence of atherosclerosis by means of macroangiopathy. The results of the Diabetes Control and Complications Trial (DCCT),7 on the other hand, clearly demonstrate that retinopathy and nephropathy but not coronary artery disease or peripheral artery disease are manifestations of diabetic angiopathy in relatively young patients under bad glycemic control. Since the patients described in Dr Johnstone's article were under an even worse glycemic control than the conventional treatment group in the DCCT (patients were on long-lasting insulin preparations; HbA1 was 11.9±0.6%), a remarkable number of patients with either retinopathy or nephropathy must have been included. This very critical point, however, was not investigated or documented by the authors. Thus, no information on diabetic vascular complications is provided in the article. Therefore, the diabetic group must have been inhomogenous regarding the stage of diabetic angiopathy and thus inhomogenous regarding vascular reactivity. Thus, a general conclusion of impaired endothelium-dependent relaxation in type I diabetes as a manifestation of endothelial dysfunction, in our opinion, must not be drawn by these results. Much more information could have been obtained comparing patients with different stages of true diabetic vascular complications.
Based on our findings and the results of other groups mentioned above, we suggest the possibility of a time course of endothelial dysfunction in diabetes mellitus type I: increased vasodilation based on increased formation of endothelium-derived relaxing factor at the beginning of the disease followed by "pseudonormalization" of endothelial function and finally reduced endotheliumdependent relaxation and manifestation of morphologically overt diabetic angiopathy. The mechanisms mediating this chronology of endothelial dysfunction remain to be investigated, but endothelial cell defects of L-arginine metabolism8 as well as reduced smooth muscle cell function9 as seen in hypercholesterolemia might be involved.
Thomas 
Reply
We appreciate the comments of Dr Wascher and colleagues, who suggest that synthesis of endothelium-derived nitric oxide may be increased in patients with diabetes mellitus before the onset of vascular complications. They cite two studies to support their contention. 12 Corbett et all reported that aminoguanidine and N0-monomethyl-L-arginine inhibited interleukin 13-induced nitrite and cGMP formation from RINn5F cells and reduced blood flow in hyperglycemic and diabetic rats. These findings, however, may be more relevant to inducible than constitutive nitric oxide formation and differ from those reported by Bucala and colleagues,3 who found that aminoguanidine improved endotheliumdependent relaxation when administered prophylactically to diabetic rats. Graier et a12 reported that high concentrations of D-glucose (44 mol/L) increased calcium mobilization and cGMP formation in porcine aortic endothelial cells. Yet, in other experimental models of hyperglycemia, high concentrations of glucose decreased Na+-K+ ATPase activity, enhanced activity of protein kinase C, and increased production of vasoconstrictor prostanoids, actions that might impair endothelium-dependent relaxation.4-6 Thus, it is often difficult to extrapolate observations made in vitro to the whole organism, in which a variety of factors may account for nitric oxide synthesis and degradation. The majority of reports, both in vitro and in vivo, cited in our article7 and in a recent review8 have found that endothelium-dependent relaxation is impaired in experimental models of diabetes and in patients with diabetes mellitus. Our data demonstrate that endothelium-dependent relaxation is abnormal in a cross section of patients with insulin-dependent diabetes mellitus7 but do not allow us to determine when this abnormality occurs in relation to the onset of vascular complications. We found no correlation between either the duration of diabetes or control of hyperglycemia and endothelial function. Five of the 15 patients with diabetes mellitus had funduscopic evidence of retinopathy. The highest dose of the endothelium-dependent vasodilator methacholine chloride increased forearm blood flow 9.5±1.5 mL per 100 mL/min in patients with retinopathy and 9.6±1.5 mL per 100 mL/min in the group of patients without retinopathy (P=NS). All patients had normal renal function as determined by blood urea nitrogen and serum creatinine concentrations. It is possible that either fluorescein angiography or urinary albumin determination would have enabled us to detect a greater number of patients with evidence of microvascular disease. Our results differ from those of Smits et al,9 who found neither augmentation nor impairment of endotheliumdependent vasodilation in a smaller study of insulin-dependent diabetics who had no microvascular complications.
The correspondents' implications regarding the Diabetes Control and Complications Trial'0 are somewhat misleading. The primary objective of that study was to assess the effect of glucose control on the development of retinopathy, and the study was not powered to evaluate the effect of intensive treatment on macrovascular complications. Nonetheless, intensive therapy reduced the risk of macrovascular disease by 41%, a value that did not quite achieve statistical significance. Thus, unfortunately, atherosclerosis is a frequently encountered complication of young diabetic patients. It remains to be determined whether reduced activity of endothelium-derived nitric oxide contributes to atherogenesis in these individuals.
Based on our findings7 and those reported by Calver et al,"l we conclude that endothelium-dependent vasodilation is abnormal in forearm resistance vessels of most patient with insulin-dependent diabetes mellitus and think it is unlikely that enhanced synthesis of endothelium-derived nitric oxide accounts for preserved or increased blood flow in selected regional circulations. In our article, we suggested a number of mechanisms that may explain abnormal endothelial function in these patients, including reduced synthesis or accelerated inactivation of nitric oxide. We have shown previously that L-arginine improves endothelium-dependent relaxation in forearm resistance vessels of hypercholesterolemic humans'2 and agree that this approach should be explored in patients with diabetes. It is unlikely that vascular smooth muscle reactivity was impaired in our patients because their forearm blood flow responses to nitroprusside, verapamil, and phenylephrine were similar to that observed in normal subjects.
